Canndeo® Ltd is a wholly owned subsidiary of The Hydroponics Company Limited, and an ASX listed Australian company (ASX:THC) which is focused on formulating, developing and commercialising quality medicinal cannabis therapies for the Australian and international markets.
Canndeo was established for supplying GMP-certified medicinal cannabis therapies to the Australian market. It is our intention to develop a portfolio of therapies to support prescriber acceptance and patient compliance by providing quality medicinal cannabis therapies with consistent and reliable drug dosing. All products supplied by Canndeo meet requirements established by the Therapeutic Goods Association (TGA).
With a strong commitment to quality and compliance as well as growing the clinical evidence and knowledge of medicinal cannabis, Canndeo continues to invest in research and studies to generate clinical data on the efficacy and safety of medicinal cannabis therapies to support informed prescribing and improve patient outcomes.
Canndeo is the Australian authorised importer of Endoca products.